Side Effect Profile of 200 Patients with Inflammatory Arthritides Treated with Sulphasalazine1

Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator Phenotype

1973 • 451 citations

Sulfasalazine

1984 • 233 citations

Sulphasalazine in rheumatoid arthritis.

1980 • 176 citations

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.

1983 • 168 citations

Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

1983 • 124 citations

Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.

1985 • 89 citations

Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.

1984 • 70 citations

A biochemical assessment of sulphasalazine in rheumatoid arthritis.

1982 • 63 citations

SULPHASALAZINE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: RELATIONSHIP OF DOSE AND SERUM LEVELS TO EFFICACY

1985 • 60 citations

Sulphasalazine desensitisation.

1981 • 49 citations

The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine

1984 • 36 citations

Efficiency of haematological screening tests for detecting disease.

1981 • 28 citations

Neutropenia in patients with inflammatory arthritis treated with sulphasalazine.

1986 • 18 citations

Rheumatoid Arthritis: The Treatment Controversy

1984 • 12 citations

Gold in the treatment of rheumatoid arthritis

1984 • 6 citations